VIR
VIR
NASDAQ · Biotechnology

Vir Biotechnology Inc

$8.57
-0.27 (-3.05%)
As of Mar 24, 10:03 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +98.1% upside
Low Target $13.41
Average Target $16.98
High Target $22.24
Current Price $8.57
Current
$8.57
Target
$16.98
$13.41 $16.98 avg $22.24
Scenario Analysis
Bear Case
$13.41
56.5%
Low target
Base Case
$16.98
+98.1%
Avg target
Bull Case
$22.24
+159.5%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$9.97
-14.0% from high
52-Week Low
$4.16
+106.3% from low
Target vs 52W High
$16.98
+70.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%